Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension
Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension
复制标题
DOI：
10.1592/phco.20.17.1384.34891
复制
发表时间：
2000-11-01
期刊：
影响因子：
4.1
通讯作者：
MacLaughlin, EJ
中科院分区：
文献类型：
--
作者：
Mehos, BM;Saseen, JJ;MacLaughlin, EJ
这项前瞻性、随机、对照研究评价了药师发起的家庭血压监测和干预对血压控制、治疗依从性和生活质量（QOL）的影响。受试者为36例未控制的1期或2期高血压患者。18名受试者接受了家庭血压监测仪、日记和每天早晨测量两次血压的指导。家庭测量由临床药剂师通过电话进行评估，如果每月平均值为140/90 mm Hg或更高，则联系患者的家庭医生并提出建议。十八控制。患者没有接受家庭监测或药剂师干预。在基线和6个月后获得办公室血压测量和QOL调查（SF-36）。干预组收缩压和舒张压的平均绝对下降值较基线显著降低（17.0和10.5 mm Hg，均P
This prospective, randomized, controlled study evaluated the impact of pharmacist-initiated home blood pressure monitoring and intervention on blood pressure control, therapy compliance, and quality of life (QOL). Subjects were 36 patients with uncontrolled stage 1 or 2 hypertension. Eighteen subjects received home blood pressure monitors, a diary, and instructions to measure blood pressure twice every morning. Home measurements were evaluated by a clinical pharmacist by telephone, and the patient's family physician was contacted with recommendations if mean monthly values were 140/90 mm Hg or higher. Eighteen control. patients did not receive home monitors or pharmacist intervention Office blood pressure measurements and QOL surveys (SF-36) were obtained at baseline and after 6 months. Mean absolute reductions in systolic and diastolic pressures were significantly reduced from baseline in intervention subjects (17.0 and 10.5 mm Hg, both p